Clinical trial
Effect of MD1003 in Amyotrophic Lateral Sclerosis: a Randomized Double Blind Placebo Controlled Pilot Study
NCT03114215 is registered in ClinicalTrials.gov with MedDay Pharmaceuticals SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of MD1003 in Amyotrophic Lateral Sclerosis: a Randomized Double Blind Placebo Controlled Pilot Study
- Lead sponsor
- MedDay Pharmaceuticals SA
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 29, 2016
- Completion date
- December 31, 2017
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.